Inflammatory regulatory T cells in the microenvironments of ulcerative colitis and colon carcinoma

OncoImmunology

Volumn 5, Issue 8, 2016, Pages

  Kryczek, Ilona ^a   Wang, Lin ^b   Wu, Ke ^a,b   Li, Wei ^a,b   Zhao, Ende ^a,b   Cui, Tracy ^a   Wei, Shuang ^a   Liu, Yan ^a   Wang, Yin ^a   Vatan, Linda ^a   Szeliga, Wojciech ^a   Greenson, Joel K ^a   Roliński, Jacek ^c   Zgodzinski, Witold ^c   Huang, Emina ^d   Tao, Kaixiong ^b   Wang, Guobin ^b   Zou, Weiping ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^c MEDICAL UNIVERSITY OF LUBLIN   (Poland)

^d CASE WESTERN RESERVE UNIVERSITY   (United States)

Author keywords

Colon carcinoma; IL 17; IL 8; neutrophil; Regulatory T cell; Th17; tumor immunity; ulcerative colitis

Indexed keywords

CD4 ANTIGEN; CHEMOKINE RECEPTOR CXCR5; GAMMA INTERFERON; INTERLEUKIN 17; INTERLEUKIN 2; INTERLEUKIN 7 RECEPTOR; INTERLEUKIN 8; TRANSCRIPTION FACTOR FOXP3; TRANSFORMING GROWTH FACTOR BETA;

ARTICLE; BIOLOGICAL ACTIVITY; CELL MIGRATION ASSAY; CELL PROLIFERATION; COLON CARCINOMA; CONTROLLED STUDY; CYTOKINE PRODUCTION; FLOW CYTOMETRY; GENE EXPRESSION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IMMUNOFLUORESCENCE TEST; LUCIFERASE ASSAY; MRNA EXPRESSION ASSAY; OVARY CARCINOMA; POLYMERASE CHAIN REACTION; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE; TUMOR IMMUNITY; TUMOR MICROENVIRONMENT; ULCERATIVE COLITIS;

EID: 84983784448     PISSN: 21624011     EISSN: 2162402X     Source Type: Journal    
DOI: 10.1080/2162402X.2015.1105430     Document Type: Article

References (48)

1. A.D.Luster. The role of chemokines in linking innate and adaptive immunity. Curr Opin Immunol 2002; 14:129-35; PMID:11790543; http://dx.doi.org/10.1016/S0952-7915(01)00308-9
2. K.J.Wood, S.Sakaguchi. Regulatory Lymphocytes:Regulatory T cells in transplantation tolerance. Nat Rev Immunol 2003; 3:199-210; PMID:12658268; http://dx.doi.org/10.1038/nri1027
3. M.G.Von Herrath, L.C.Harrison. Regulatory Lymphocytes:Antigen-induced regulatory T cells in autoimmunity. Nat Rev Immunol 2003; 3:223-32; PMID:12658270; http://dx.doi.org/10.1038/nri1029
4. E.M.Shevach. CD4+ CD25+ suppressor T cells:more questions than answers. Nat Rev Immunol 2002; 2:389-400; PMID:12093005
5. J.Francois Bach. Regulatory lymphocytes:Regulatory T cells under scrutiny. Nat Rev Immunol 2003; 3:189-98; PMID:12658267; http://dx.doi.org/10.1038/nri1026
6. M.G.Roncarolo, S.Gregori, M.Levings. Type 1 T regulatory cells and their relationship with CD4+CD25+ T regulatory cells. Novartis Found Symp 2003; 252:115-27; discussion 27-31, 203-10; PMID:14609215; http://dx.doi.org/10.1002/0470871628.ch9
7. W.Zou. Immunosuppressive networks in the tumour environment and their therapeutic relevance. Nature reviews Cancer 2005; 5:263-74; PMID:15776005; http://dx.doi.org/10.1038/nrc1586
8. P.Yu, Y.Lee, W.Liu, T.Krausz, A.Chong, H.Schreiber, Y.X.Fu. Intratumor depletion of CD4+ cells unmasks tumor immunogenicity leading to the rejection of late-stage tumors. J Exp Med 2005; 201:779-91; PMID:15753211; http://dx.doi.org/10.1084/jem.20041684
9. I.Kryczek, R.Liu, G.Wang, K.Wu, X.Shu, W.Szeliga, L.Vatan, E.Finlayson, E.Huang, D.Simeone et al. FOXP3 defines regulatory T cells in human tumor and autoimmune disease. Cancer Res 2009; 69:3995-4000; PMID:19383912; http://dx.doi.org/10.1158/0008-5472.CAN-08-3804
10. T.J.Curiel, G.Coukos, L.Zou, X.Alvarez, P.Cheng, P.Mottram, M.Evdemon-Hogan, J.R.Conejo-Garcia, L.Zhang, M.Burow et al. Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival. Nat Med 2004; 10:942-9; PMID:15322536; http://dx.doi.org/10.1038/nm1093
11. S.Wei, I.Kryczek, W.Zou. Regulatory T-cell compartmentalization and trafficking. Blood 2006; 108:426-31; PMID:16537800; http://dx.doi.org/10.1182/blood-2006-01-0177
12. I.Kryczek, M.Banerjee, P.Cheng, L.Vatan, W.Szeliga, S.Wei, E.Huang, E.Finlayson, D.Simeone, T.H.Welling et al. Phenotype, distribution, generation, and functional and clinical relevance of Th17 cells in the human tumor environments. Blood 2009; 114:1141-9; PMID:19470694; http://dx.doi.org/10.1182/blood-2009-03-208249
13. I.Kryczek, A.T.Bruce, J.E.Gudjonsson, A.Johnston, A.Aphale, L.Vatan, W.Szeliga, Y.Wang, Y.Liu, T.H.Welling et al. Induction of IL-17+ T cell trafficking and development by IFN-gamma:mechanism and pathological relevance in psoriasis. J Immunol 2008; 181:4733-41; PMID:18802076; http://dx.doi.org/10.4049/jimmunol.181.7.4733
14. D.C.Baumgart, S.R.Carding. Inflammatory bowel disease:cause and immunobiology. Lancet 2007; 369:1627-40; PMID:17499605; http://dx.doi.org/10.1016/S0140-6736(07)60750-8
15. W.Chen, W.Jin, N.Hardegen, K.J.Lei, L.Li, N.Marinos, G.McGrady, S.M.Wahl. Conversion of peripheral CD4+CD25- naive T cells to CD4+CD25+ regulatory T cells by TGF-beta induction of transcription factor Foxp3. J Exp Med 2003; 198:1875-86; PMID:14676299; http://dx.doi.org/10.1084/jem.20030152
16. S.Wei, I.Kryczek, R.P.Edwards, L.Zou, W.Szeliga, M.Banerjee, M.Cost, P.Cheng, A.Chang, B.Redman et al. Interleukin-2 Administration Alters the CD4+FOXP3+ T-Cell Pool and Tumor Trafficking in Patients with Ovarian Carcinoma. Cancer Res 2007; 67:7487-94; PMID:17671219; http://dx.doi.org/10.1158/0008-5472.CAN-07-0565
17. W.Zou. Regulatory T cells, tumour immunity and immunotherapy. Nat Rev Immunol 2006; 6:295-307; PMID:16557261; http://dx.doi.org/10.1038/nri1806
18. M.E.Himmel, S.Q.Crome, S.Ivison, C.Piccirillo, T.S.Steiner, M.K.Levings. Human CD4+ FOXP3+ regulatory T cells produce CXCL8 and recruit neutrophils. European J Immunol 2011; 41:306-12; PMID:21268001; http://dx.doi.org/10.1002/eji.201040459
19. F.Pallone, G.Monteleone. Mechanisms of tissue damage in inflammatory bowel disease. Curr Opin Gastroenterol 2001; 17:307-12; PMID:17031175; http://dx.doi.org/10.1097/00001574-200107000-00002
20. G.McCormack, D.Moriarty, D.P.O'Donoghue, P.A.McCormick, K.Sheahan, A.W.Baird. Tissue cytokine and chemokine expression in inflammatory bowel disease. Inflamm Res 2001; 50:491-5; PMID:11713901; http://dx.doi.org/10.1007/PL00000223
21. Y.Murata, Y.Ishiguro, J.Itoh, A.Munakata, Y.Yoshida. The role of proinflammatory and immunoregulatory cytokines in the pathogenesis of ulcerative colitis. J Gastroenterol 1995; 30 Suppl 8:56-60; PMID:8563892
22. D.C.Baumgart, W.J.Sandborn. Inflammatory bowel disease:clinical aspects and established and evolving therapies. Lancet 2007; 369:1641-57; PMID:17499606; http://dx.doi.org/10.1016/S0140-6736(07)60751-X
23. L.M.Coussens, Z.Werb. Inflammation and cancer. Nature 2002; 420:860-7; PMID:12490959; http://dx.doi.org/10.1038/nature01322
24. C.Ginestier, S.Liu, M.E.Diebel, H.Korkaya, M.Luo, M.Brown, J.Wicinski, O.Cabaud, E.Charafe-Jauffret, D.Birnbaum et al. CXCR1 blockade selectively targets human breast cancer stem cells in vitro and in xenografts. J Clin Invest 2010; 120:485-97; PMID:20051626; http://dx.doi.org/10.1172/JCI39397
25. I.Kryczek, Y.Lin, N.Nagarsheth, D.Peng, L.Zhao, E.Zhao, L.Vatan, W.Szeliga, Y.Dou, S.Owens et al. IL-22CD4 T Cells Promote Colorectal Cancer Stemness via STAT3 Transcription Factor Activation and Induction of the Methyltransferase DOT1L. Immunity 2014; 40(5):772-84; PMID:24816405; http://dx.doi.org/10.1016/j.immuni.2014.03.010
26. T.X.Cui, I.Kryczek, L.Zhao, E.Zhao, R.Kuick, M.H.Roh, L.Vatan, W.Szeliga, Y.Mao, D.G.Thomas et al. Myeloid-derived suppressor cells enhance stemness of cancer cells by inducing microRNA101 and suppressing the corepressor CtBP2. Immunity 2013; 39:611-21; PMID:24012420; http://dx.doi.org/10.1016/j.immuni.2013.08.025
27. M.C.Grimm, S.K.Elsbury, P.Pavli, W.F.Doe. Interleukin 8:cells of origin in inflammatory bowel disease. Gut 1996; 38:90-8; PMID:8566866; http://dx.doi.org/10.1136/gut.38.1.90
28. L.Mazzucchelli, C.Hauser, K.Zgraggen, H.Wagner, M.Hess, J.A.Laissue, C.Mueller. Expression of interleukin-8 gene in inflammatory bowel disease is related to the histological grade of active inflammation. Am J Pathol 1994; 144:997-1007; PMID:8178948
29. G.Monteleone, T.Parrello, I.Monteleone, S.Tammaro, F.Luzza, F.Pallone. Interferon-gamma (IFN-gamma) and prostaglandin E2 (PGE2) regulate differently IL-12 production in human intestinal lamina propria mononuclear cells (LPMC). Clin Exp Immunol 1999; 117:469-75; PMID:10469049; http://dx.doi.org/10.1046/j.1365-2249.1999.00991.x
30. J.J.O'Shea, W.E.Paul. Mechanisms underlying lineage commitment and plasticity of helper CD4+ T cells. Science 2010; 327:1098-102; PMID:20185720; http://dx.doi.org/10.1126/science.1178334
31. C.T.Weaver, R.D.Hatton. Interplay between the TH17 and TReg cell lineages:a (co-)evolutionary perspective. Nat Rev Immunol 2009; 9:883-9; PMID:19935807; http://dx.doi.org/10.1038/nri2660
32. D.Mucida, Y.Park, G.Kim, O.Turovskaya, I.Scott, M.Kronenberg, H.Cheroutre. Reciprocal TH17 and regulatory T cell differentiation mediated by retinoic acid. Science 2007; 317:256-60; PMID:17569825; http://dx.doi.org/10.1126/science.1145697
33. E.Bettelli, Y.Carrier, W.Gao, T.Korn, T.B.Strom, M.Oukka, H.L.Weiner, V.K.Kuchroo. Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature 2006; 441:235-8; PMID:16648838; http://dx.doi.org/10.1038/nature04753
34. K.S.Voo, Y.H.Wang, F.R.Santori, C.Boggiano, Y.H.Wang, K.Arima, L.Bover, S.Hanabuchi, J.Khalili, E.Marinova et al. Identification of IL-17-producing FOXP3+ regulatory T cells in humans. Proc Natl Acad Sci U S A 2009; 106:4793-8; PMID:19273860; http://dx.doi.org/10.1073/pnas.0900408106
35. G.Beriou, C.M.Costantino, C.W.Ashley, L.Yang, V.K.Kuchroo, C.Baecher-Allan, D.A.Hafler. IL-17-producing human peripheral regulatory T cells retain suppressive function. Blood 2009; 113:4240-9; PMID:19171879; http://dx.doi.org/10.1182/blood-2008-10-183251
36. M.Ayyoub, F.Deknuydt, I.Raimbaud, C.Dousset, L.Leveque, G.Bioley, D.Valmori. Human memory FOXP3+ Tregs secrete IL-17 ex vivo and constitutively express the T(H)17 lineage-specific transcription factor RORgamma t. Proc Natl Acad Sci U S A 2009; 106:8635-40; PMID:19439651; http://dx.doi.org/10.1073/pnas.0900621106
37. L.Zhou, J.E.Lopes, M.M.Chong, I.I.Ivanov, R.Min, G.D.Victora, Y.Shen, J.Du, Y.P.Rubtsov, A.Y.Rudensky et al. TGF-beta-induced Foxp3 inhibits T(H)17 cell differentiation by antagonizing RORgammat function. Nature 2008; 453:236-40; PMID:18368049; http://dx.doi.org/10.1038/nature06878
38. W.Zou, V.Machelon, A.Coulomb-L'Hermin, J.Borvak, F.Nome, T.Isaeva, S.Wei, R.Krzysiek, I.Durand-Gasselin, A.Gordon et al. Stromal-derived factor-1 in human tumors recruits and alters the function of plasmacytoid precursor dendritic cells. Nat Med 2001; 7:1339-46; PMID:11726975; http://dx.doi.org/10.1038/nm1201-1339
39. T.J.Curiel, S.Wei, H.Dong, X.Alvarez, P.Cheng, P.Mottram, R.Krzysiek, K.L.Knutson, B.Daniel, M.C.Zimmermann et al. Blockade of B7-H1 improves myeloid dendritic cell-mediated antitumor immunity. Nat Med 2003; 9:562-7; PMID:12704383; http://dx.doi.org/10.1038/nm863
40. I.Kryczek, L.Zou, P.Rodriguez, G.Zhu, S.Wei, P.Mottram, M.Brumlik, P.Cheng, T.Curiel, L.Myers et al. B7-H4 expression identifies a novel suppressive macrophage population in human ovarian carcinoma. J Exp Med 2006; 203:871-81; PMID:16606666; http://dx.doi.org/10.1084/jem.20050930
41. I.Kryczek, S.Wei, E.Keller, R.Liu, W.Zou. Stroma-derived factor (SDF-1/CXCL12) and human tumor pathogenesis. Am J Physiol Cell Physiol 2007; 292:C987-95; PMID:16943240; http://dx.doi.org/10.1152/ajpcell.00406.2006
42. H.Yssel, H.Spits. Generation and maintenance of cloned human T cell lines. Curr Protoc Immunol 2002; Chapter 7:Unit 7 19; PMID:18432890; http://dx.doi.org/10.1002/0471142735.im0719s47
43. T.X.Cui, G.Piwien-Pilipuk, J.S.Huo, J.Kaplani, R.Kwok, J.Schwartz. Endogenous CCAAT/enhancer binding protein beta and p300 are both regulated by growth hormone to mediate transcriptional activation. Mol Endocrinol 2005; 19:2175-86; PMID:15860545; http://dx.doi.org/10.1210/me.2004-0502
44. T.J.Sadlon, B.G.Wilkinson, S.Pederson, C.Y.Brown, S.Bresatz, T.Gargett, E.L.Melville, K.Peng, R.J.D'Andrea, G.G.Glonek et al. Genome-wide identification of human FOXP3 target genes in natural regulatory T cells. J Immunol 2010; 185:1071-8; PMID:20554955; http://dx.doi.org/10.4049/jimmunol.1000082
45. D.Zhao, A.C.Keates, S.Kuhnt-Moore, M.P.Moyer, C.P.Kelly, C.Pothoulakis. Signal transduction pathways mediating neurotensin-stimulated interleukin-8 expression in human colonocytes. J Biol Chem 2001; 276:44464-71; PMID:11574537; http://dx.doi.org/10.1074/jbc.M104942200
46. H.Wang, F.Moreau, C.L.Hirota, W.K.MacNaughton. Proteinase-activated receptors induce interleukin-8 expression by intestinal epithelial cells through ERK/RSK90 activation and histone acetylation. FASEB J 2010; 24:1971-80; PMID:20065107; http://dx.doi.org/10.1096/fj.09-137646
47. T.Zuo, L.Wang, C.Morrison, X.Chang, H.Zhang, W.Li, Y.Liu, Y.Wang, X.Liu, M.W.Chan et al. FOXP3 is an X-linked breast cancer suppressor gene and an important repressor of the HER-2/ErbB2 oncogene. Cell 2007; 129:1275-86; PMID:17570480; http://dx.doi.org/10.1016/j.cell.2007.04.034
48. C.H.Olsen. Review of the use of statistics in infection and immunity. Infect Immun 2003; 71:6689-92; PMID:14638751; http://dx.doi.org/10.1128/IAI.71.12.6689-6692.2003